Disseminated Cryptococcosis Complicating Severe SARS-CoV-2 Infection

Opportunistic invasive fungal infections (IFI) have been described in severe SARS-CoV-2 infection. COVID-19-related cytokine storm, immune dysregulation and lymphopenia may increase IFI susceptibility in comorbid patients. We described the case of a 64-year-old man with respiratory failure due to SARS-CoV-2 infection complicated with disseminated cryptococosis. We analyzed the role played by the SARS-CoV-2-associated lymphopenia and the cumulative risk factors that lead to secondary infection by Cryptococcus neoformans, and its part in the dysregulation of the immunity response.

[1]  C. Franco-Paredes,et al.  Missed opportunities to identify cryptococcosis in COVID-19 patients: a case report and literature review , 2022, Therapeutic advances in infectious disease.

[2]  Melanie Malave Sanchez,et al.  Pulmonary aspergillosis and cryptococcosis as a complication of COVID-19 , 2022, Medical Mycology Case Reports.

[3]  Armanul Amin,et al.  Root Causes of Fungal Coinfections in COVID-19 Infected Patients , 2021, Infectious disease reports.

[4]  Yerandy Gil,et al.  The Emergence of Cryptococcemia in COVID-19 Infection: A Case Report , 2021, Cureus.

[5]  S. Craver,et al.  An Uncommon Presentation of Cryptococcal Meningitis in an Immunocompetent Patient: A Case Report , 2021, Clinical practice and cases in emergency medicine.

[6]  Á. Soriano,et al.  Disseminated Cryptococcus neoformans infection associated to COVID-19 , 2021, Medical Mycology Case Reports.

[7]  K. Mondy,et al.  Cryptococcus neoformans blood stream infection in severe COVID-19 pneumonia , 2021, IDCases.

[8]  H. Ghanem,et al.  Cryptococcus neoformans Meningoencephalitis in an Immunocompetent Patient after COVID-19 Infection , 2021, Case reports in infectious diseases.

[9]  Bappaditya Ray,et al.  Cryptococcal Meningoencephalitis During Convalescence From Severe COVID-19 Pneumonia , 2021, The Neurohospitalist.

[10]  Efrain Garcia,et al.  High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections , 2021, Discoveries.

[11]  F. Messina,et al.  Infecciones fúngicas en pacientes con COVID-19 , 2021 .

[12]  T. Lamarre,et al.  Opportunistic Fungal Infection Associated With COVID-19 , 2021, Open forum infectious diseases.

[13]  A. Nashwan,et al.  Cryptococcemia in a patient with COVID‐19: A case report , 2020, Clinical case reports.

[14]  B. Edlow,et al.  Case 40-2020: A 24-Year-Old Man with Headache and Covid-19 , 2020, New England Journal of Medicine.

[15]  J. Routy,et al.  Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System , 2020, Frontiers in Immunology.

[16]  A. Perosa,et al.  Detected SARS-CoV-2 in Ascitic Fluid Followed by Cryptococcemia: a Case Report , 2020, SN Comprehensive Clinical Medicine.

[17]  E. Quint,et al.  Autoimmune Hemolytic Anemia in a 24-Year-Old Patient With COVID-19 Complicated by Secondary Cryptococcemia and Acute Necrotizing Encephalitis: A Case Report and Review of Literature , 2020, Journal of medical cases.

[18]  S. Piconi,et al.  Disseminated Cryptococcosis in a Patient With Metastatic Prostate Cancer Who Died in the Coronavirus Disease 2019 (COVID-19) Outbreak , 2020, Cureus.

[19]  L. Kou,et al.  Pulmonary cryptococcosis characteristics in immunocompetent patients—A 20‐year clinical retrospective analysis in China , 2019, Mycoses.

[20]  C. Franco-Paredes,et al.  Treatment of cryptococcosis in non-HIV immunocompromised patients , 2018, Current opinion in infectious diseases.

[21]  Wenhong Zhang,et al.  Disseminated cryptococcosis with recurrent multiple abscesses in an immunocompetent patient: a case report and literature review , 2017, BMC Infectious Diseases.

[22]  W. Liao,et al.  Systemic Review of Published Reports on Primary Cutaneous Cryptococcosis in Immunocompetent Patients , 2015, Mycopathologia.

[23]  J. Baddley,et al.  Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune Status , 2013, PloS one.

[24]  W. Xiaojun,et al.  Cryptococcal meningitis in immunocompetent children , 2011, Mycoses.

[25]  C. D'souza,et al.  Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box , 2011, Nature Reviews Microbiology.

[26]  So Ri Kim,et al.  Pulmonary cryptococcosis in asymptomatic immunocompetent hosts , 2009, Scandinavian journal of infectious diseases.

[27]  A. Zaas,et al.  Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[28]  A. Casadevall,et al.  Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T‐cells through activation of caspase‐8 , 2006, Cellular microbiology.

[29]  A. Casadevall,et al.  Intracellular parasitism of macrophages by Cryptococcus neoformans. , 2001, Trends in microbiology.

[30]  G. Teti,et al.  Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components , 1997, Infection and immunity.

[31]  F. Bistoni,et al.  Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils , 1996, Infection and immunity.

[32]  T. Kozel,et al.  The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. , 1982, Journal of immunology.

[33]  A. Forrestel,et al.  CRYPTOCOCCOSIS , 1982, The Lancet.